Table 3.
Clinicopathologic features | HR | 95% CI | P value |
---|---|---|---|
Location (vs. UTG) | 0.282 | 0.146–0.544 | P<0.001* |
Invasion depth (vs. T1–T2) | 0.955 | 0.382–2.389 | P=0.922 |
TNM stage (vs. I–II) | 2.726 | 1.052–7.066 | P=0.039* |
USP33 expression (vs. low) | 0.432 | 0.223–0.839 | P=0.013* |
UTG – upper third gastric; USP33 – ubiquitin specific peptidase 33.